Ask a biotech operation where its skills gaps are and biochemistry rarely comes up. Bioinformatics, process engineering, regulatory affairs, yes. Biochemistry sounds like something people did at university.
Then a batch fails, a protein comes out of solution, an enzyme loses activity three months into a campaign, and the question in the room is a biochemistry question that nobody present can answer quickly.
The direction that gets skipped
The scope: biomolecules, enzymes and metabolism. Proteins, lipids and carbohydrates, and the chemistry of living systems.
That sounds foundational, and it is, but it is also operational in a way that gets missed. Biochemistry is where behaviour gets explained.
Molecular biology tells you what the cell is doing. Biochemistry tells you why the thing you made is behaving the way it is, under the conditions you have put it in.
Molecular biology explains the organism. Biochemistry explains the product, and the product is what the business sells.
What it covers, and why industry cares
Four areas carry most of the industrial weight.
Protein structure and stability. Biologics are proteins, and proteins are fragile. Temperature, pH, ionic strength, shear, surfaces and freeze-thaw all affect whether a protein stays folded and soluble. Aggregation is one of the most common and most expensive problems in biologics development, and it is a biochemistry problem.
Enzymes and kinetics. Industrial biotechnology runs on enzymes. How fast they work, what inhibits them, how they behave at process temperature and pH, and how long they last decide whether a process is economic.
Metabolism. What a cell does with the feed it is given, where the carbon goes, which by-products accumulate and inhibit growth. Central to fermentation yield and to why a scale-up behaves differently from the bench.
Analytical biochemistry. Chromatography, spectroscopy, electrophoresis, mass spectrometry. Every quality decision in the industry rests on an analytical method, and someone has to develop, validate and troubleshoot those methods.
Four expensive problems that are biochemistry problems
The yield that dropped and nobody can explain. A fermentation that performed for six months starts underperforming. Raw material lot change, a shifted by-product profile, an enzyme operating slightly outside its window. Diagnosing this requires someone who can reason about the chemistry rather than compare run charts.
The formulation that fails on stability. A product that looked fine at release aggregates or degrades over shelf life. Expensive, because it surfaces late, and preventable by people who understand protein behaviour at formulation stage.
The assay that drifts. A quality control method that gradually shifts, so results are no longer comparable across time. Frequently reagent chemistry or enzyme activity, and frequently misdiagnosed as an instrument problem.
The process that will not scale. Works at two litres, fails at two thousand. Often mass transfer and mixing, and often also the chemistry: oxygen availability, local pH, shear on a fragile molecule.
Each of these costs more than a training program. None of them appears in a workforce plan as a biochemistry gap, because they are recorded as a batch failure, a stability issue, an instrument problem and a scale-up delay.
Where this sits in the domain
Biochemistry is the second of ten directions in Astra Trainer's biotechnology domain, sitting between cell and molecular biology and genetics and genomics, and feeding directly into bioprocessing, drug discovery and industrial biotechnology further along.
It is the direction partners most often add after a failure investigation rather than before one. Tracks run from fundamentals to applied work and are sequenced with the partner's own scientists. Lessons are five minutes, with practice in each and a ten-question final exam per course. You can see the ten directions here.
Where the demand sits
The roles, named, because "biochemist" as a job title understates how widely this is needed.
Analytical development scientists. Developing and validating the methods that measure product quality. Chronically short in biologics.
Formulation scientists. Making a molecule stable enough to be a product. A specialised and consistently undersupplied role.
Quality control analysts and method troubleshooters. The people who keep release testing running and diagnose it when it stops.
Process development and manufacturing sciences. Root-cause analysis on production problems.
Enzyme and strain development. Central to industrial biotechnology and to food and agricultural applications.
Technical service. Supporting industrial customers using enzymes or reagents, where the questions are chemistry questions.
Structural context: McKinsey Global Institute's Bio Revolution work estimated that around 60 percent of the physical inputs to the global economy could in principle be produced biologically. Every one of those substitutions is an enzyme and metabolism problem before it is a business case.
Who can be trained into it
Analytical chemists. The strongest pool by a distance. They already have the instrumentation, method development and validation mindset. What they need is the biological substrate: why proteins behave unlike small molecules, what an enzyme assay is really measuring, why biological samples are messier.
The useful part is that analytical chemists are frequently already employed in the same organisation, in a different group, and are invisible to a workforce plan that searches on job titles.
Quality control analysts. Running methods daily and one structured step from developing and troubleshooting them.
Chemical engineers. Strong on process and transport, lighter on the molecular chemistry. This combination is exactly what scale-up problems need, and it is rare.
Molecular biologists. Understand the biology, often lighter on quantitative chemistry and analytical method. The complementary conversion to the one above.
Food science and brewing backgrounds. Practical fermentation and enzyme experience already in hand.
The regulated boundary. Analytical method validation, stability programs and quality control in pharmaceutical and food manufacturing operate under defined regulatory frameworks, and work in those environments requires role-specific qualification and documented site training. Structured learning builds the scientific understanding that makes people effective inside those frameworks. It is not a substitute for GMP or GLP qualification, and no article should be read as suggesting otherwise.
The analytical layer that comes with it
Worth separating out, because it is the part with the most immediate operational return.
Every quality decision in biotech rests on an analytical result. If the method is not understood, the decision is not really being made by anyone.
Three capabilities matter most.
Knowing what a method measures and what it misses. A method that detects total protein does not detect whether the protein is correctly folded. Confusing the two produces confident wrong answers.
Diagnosing method failure. Distinguishing a genuine product change from an instrument drift, a reagent lot issue or an analyst technique difference. This capability alone prevents a substantial amount of unnecessary investigation.
Developing a method that survives transfer. A method that works in one laboratory with one analyst is not yet a method. Robustness is a design property and it is designed in by people who understand the chemistry.
What to take from this
Biochemistry is a diagnostic capability, not academic background, and it gets skipped because its failures are recorded under other names.
Protein stability, enzyme performance, metabolic behaviour and analytical method development are all the same underlying discipline, and all four are expensive when thin.
Analytical chemists are the best training pool available and are frequently already inside the organisation.
The chemical engineer who understands molecular chemistry, and the molecular biologist who understands analytical method, are both rare and both are conversions rather than hires.
And the return shows up as failures that did not happen, which is real and hard to attribute, so it needs to be argued for before the failure rather than after it.
Why does biochemistry matter commercially?
Because it explains product behaviour. Protein aggregation, enzyme performance, yield loss and analytical drift are all biochemistry problems, and each is more expensive than a training program.
Who is best placed to move into these roles?
Analytical chemists, by a distance. They hold the method development and validation mindset and need the biological substrate. Quality control analysts are the next closest.
What roles does this direction feed?
Analytical development, formulation, quality control troubleshooting, process development and manufacturing sciences, enzyme and strain development, and technical service.
Does this replace GMP or GLP qualification?
No. Regulated laboratory and manufacturing work requires role-specific qualification and documented site training. Training builds the scientific understanding that makes people effective within those frameworks.
Where does this fit in the domain?
Second of ten directions in Astra Trainer's biotechnology domain, feeding into bioprocessing, drug discovery and industrial biotechnology. You can see them here.